Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Techne (TECH) Curent Deferred Tax Liability (2012 - 2013)

Bio-Techne's quarterly Curent Deferred Tax Liability came in at $9.9 million in Q2 2013, down 30.14% year-on-year from $14.2 million in Q2 2012, and down 1.23% quarter-over-quarter from $10.1 million in Q1 2013.

Bio-Techne has reported Curent Deferred Tax Liability for 2 years, with the latest figure at $9.9 million in Q2 2013.

  • For the quarter ending Q2 2013, Curent Deferred Tax Liability fell 30.14% year-over-year to $9.9 million; the trailing twelve-month figure through Jun 2013 stood at $9.9 million (down 30.14% YoY), and the FY2013 full-year result was $9.9 million, down 30.14% from the prior year.
  • Curent Deferred Tax Liability for Q2 2013 stood at $9.9 million, down from $10.1 million in the prior quarter.
  • The five-year high for Curent Deferred Tax Liability was $14.2 million in Q2 2012, with the low at $4.2 million in Q4 2012.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Curent Deferred Tax (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Bio-Techne 7.92 Bn 7.71 Bn 208.29 Mn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2013 9.94 Mn
Jun 30, 2013 9.94 Mn
Mar 31, 2013 10.07 Mn
Mar 31, 2013 10.07 Mn
Dec 31, 2012 4.21 Mn
Dec 31, 2012 4.21 Mn
Sep 30, 2012 6.17 Mn
Sep 30, 2012 6.17 Mn
Jun 30, 2012 14.23 Mn
Jun 30, 2012 14.23 Mn
Mar 31, 2012 4.26 Mn
Mar 31, 2012 4.26 Mn